Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
University of Washington
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Thomas Jefferson University
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
White Plains Hospital